Letter from our co-founders explaining how we have changed our work to keep people safe during this pandemic.
News & views
Our collective understanding of mental health is increasing all the time, with advances in neuroscience, psychotherapy, psychopharmacology and digital platforms.
July 23, 2019
COMPASS Pathways News | July 2019 Issue
Here are highlights of our activities in the first half of 2019 that we hope will move us closer to our goal of improving mental health care for as many as possible.
December 19, 2018
COMPASS Pathways News | December 2018 Issue
As 2018 draws to a close, we reflect on another busy year and share our highlights of the last few months with you.
November 11, 2018
Navigating mental health: COMPASS Pathways’ psilocybin research programme
Article written for the MAPS Bulletin Winter 2018. By Ekaterina Malievskaia, MD, MSc
October 23, 2018
COMPASS Pathways receives FDA Breakthrough Therapy designation for psilocybin therapy for treatment-resistant depression
COMPASS Pathways, a life sciences company dedicated to accelerating patient access to evidence-based innovation in mental health ...
July 17, 2018
COMPASS Pathways News | July 2018 Issue
This is the second of regular newsletters from COMPASS, highlighting recent and forthcoming events and developments that are relevant to us, our partners and healthcare system stakeholders.
December 19, 2017
COMPASS Pathways News | December 2017 Issue
The holiday season is approaching, and as we begin dreaming of festive treats and spending the holidays cocooned in thick duvets with a cup of hot chocolate in hand, I would like to reflect on our journey this past year and share a few 2017 highlights.